← back to search

George L. Bakris

Rush University · US
Area of research
Biochemistry · Economics and Econometrics
Research interest
Research interests include Eicosanoids and Hypertension Pharmacology, Diverse Scientific and Economic Studies, Human auditory perception and evaluation, and Blood Pressure and Hypertension Studies.
h-index
7
citations
3,040
works
32
NIH funding
primary concept
Medicine
email

Recent publications

Cardiovascular outcomes with semaglutide by severity of chronic kidney disease in type 2 diabetes: the FLOW trial
European Heart Journal 2024cited by 40position: middledoi
Effect of Finerenone on Chronic Kidney Disease Outcomes in Type 2 Diabetes
New England Journal of Medicine 2020cited by 2,581position: firstdoi
Design and Baseline Characteristics of the Finerenone in Reducing Cardiovascular Mortality and Morbidity in Diabetic Kidney Disease Trial
American Journal of Nephrology 2019cited by 208position: middledoi
Design and Baseline Characteristics of the Finerenone in Reducing Kidney Failure and Disease Progression in Diabetic Kidney Disease Trial
American Journal of Nephrology 2019cited by 177position: firstdoi

Grants

No grants ingested yet.

Frequent collaborators

Christina Nowack · Bayer (Germany)3 papers (2019–2020)Stefan D. Anker · Deutsches Herzzentrum München3 papers (2019–2020)Luís M. Ruilope · Harvard University3 papers (2019–2020)Bertram Pitt · Bayer (Germany)3 papers (2019–2020)Peter Kolkhof · Bayer (United States)3 papers (2019–2020)Patrick Schloemer · Harvard University2 papers (2019–2020)Peter Rossing · University of Glasgow2 papers (2020–2024)Rajiv Agarwal · Indiana University – Purdue University Indianapolis2 papers (2019–2019)Amer Joseph · Bayer (Germany)2 papers (2019–2020)Giuseppe Pugliese · Ospedale San Giuseppe1 papers (2024–2024)Anna Carolina Galvão Ferreira · Medical University of South Carolina1 papers (2019–2019)David Z.I. Cherney · University Health Network1 papers (2024–2024)Gil Chernin · Hebrew University of Jerusalem1 papers (2024–2024)Kenneth W. Mahaffey · Stanford University1 papers (2024–2024)Johannes F.E. Mann · Friedrich-Alexander-Universität Erlangen-Nürnberg1 papers (2024–2024)Janusz Gumprecht · Medical University of Silesia1 papers (2024–2024)Richard E. Pratley · AdventHealth Translational Research Institute1 papers (2024–2024)Ricardo Correa‐Rotter · Instituto Nacional de Ciencias Médicas y Nutrición Salvador Zubirán1 papers (2024–2024) · 1 papers (2024–2024) · 1 papers (2024–2024)